Pharma & Healthcare

Pharma & Healthcare Market Research

Where BioNixus was built — and still leads.

Pharmaceutical and healthcare research is the discipline BioNixus was founded on in London in 2012, and it remains the core of the firm. Everything else we do in B2B and B2C markets borrows the standards we set here: verified respondents, defensible sampling, and evidence built for a decision rather than a slide library.

Browse the industries index → Across-industries hub

Americas

Europe & UK

GCC & MENA

Bilingual Arabic–English fieldwork

One evidence framework

How we work

How we approach pharma & healthcare research

This is the home silo for life-sciences buyers. If your work touches a molecule, a device, a diagnosis, or a pharmacy shelf, the pages below connect to deep country and therapy coverage — physician and HCP surveys, KOL and payer research, market access and HTA support, real-world evidence, and launch readiness across the EU5, the GCC, North Africa, and the Americas.

BioNixus was founded in London and is now US-headquartered in Sheridan, Wyoming, with a MENA regional office in Greater Cairo. That footprint lets us run American and European programmes to the same standard as our GCC and North Africa fieldwork, and to benchmark a launch across all three regions inside one evidence framework.

This section sits inside the BioNixus across-industries hub, which links our pharmaceutical and healthcare work to the broader B2B and B2C research we run for the same clients.

Who briefs us

The teams that commission this work

Who briefs us here: medical affairs, commercial and brand teams, market access and HEOR leads, MedTech and diagnostics marketers, biotech founders preparing for launch, and consumer-health teams sizing OTC and pharmacy demand.

Working across more than one segment? Move between b2b industries and b2c industries — all governed by the same sampling discipline and senior-led analysis.

Coverage

Industries we cover in this segment

Each industry links to country pages across the Americas, Europe, MENA & GCC, and Asia-Pacific — GCC matrix markets use dedicated industry BOFU pages; all other hubs link to our healthcare country programmes. Follow a link to the market you are planning for, or start from the full industries index.

MedTech & Medical Devices

Medical device market research · MedTech · Hospital procurement

Healthcare Providers & Hospitals

Healthcare market research · Hospital market research · Payer research

Biotech & Life Sciences

Biotech market research · Life sciences · In vitro diagnostics

Consumer Health & OTC

Consumer health market research · OTC · Pharmacy retail

Global coverage

Countries we serve

Pharmaceutical and healthcare research across the Americas, Europe, MENA & GCC, and Asia-Pacific. Select a country hub for local fieldwork context, or browse the healthcare market research hub.

Explore

Explore in this section

Clinical diagnostics — register for full QC/IH proposal Healthcare market research hub Healthcare market research services Saudi Arabia pharmaceutical market research GCC pharmaceutical market research Pharmaceutical therapy areas Real-world evidence Research methodology

Questions

Frequently asked questions

What pharmaceutical and healthcare research does BioNixus run?

Quantitative physician and HCP surveys, qualitative KOL and payer interviews, market access and HTA support, competitive intelligence, real-world evidence, and launch readiness — across the United States, Canada, Brazil, the UK, EU5, GCC, North Africa, Turkey, and Asia-Pacific priority markets.

Does BioNixus cover the United States and the Americas for healthcare?

Yes. BioNixus was founded in London in 2012, is US-headquartered in Sheridan, Wyoming, and runs healthcare and medical-device research across the United States, Canada, and Brazil, with the same governance applied to our EMEA and GCC programmes.

How is the Pharma & Healthcare section different from the B2B and B2C sections?

This section carries the regulated, clinical, and access-driven work — pharma, MedTech, biotech, and consumer health. The B2B and B2C sections apply the same research rigor to non-healthcare categories. The BioNixus industries hub links all three.

Plan your pharma & healthcare research

Tell us the decision in front of you. We will scope the evidence to match it.

Book a discovery call →Back to the industries hub